Segment Reporting (Details)	3 Months Ended				6 Months Ended
	Jun. 30, 2025 USD ($)	Mar. 31, 2025 USD ($)	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Jun. 30, 2025 USD ($) Segment	Jun. 30, 2024 USD ($)
Segment Reporting [Abstract]
Number of operating segments | Segment					1
Number of reportable segments | Segment					1
Segment Expenses [Abstract]
Total operating expenses	$ 7,623,351		$ 8,684,304		$ 16,729,109	$ 18,781,931
Interest income	333,624		675,209		711,473	1,344,104
Interest expense	(2,144,481)		(1,187,971)		(3,075,359)	(2,362,716)
Benefit from income taxes	0		869,169		1,169,820	869,169
Net loss	(9,434,208)	$ (8,488,967)	(8,327,897)	$ (10,603,477)	(17,923,175)	(18,931,374)
Operating Segment [Member] | PDS [Member]
Segment Expenses [Abstract]
Salaries and benefits	2,857,617		4,124,151		6,686,838	8,307,421
Professional fees	1,278,581		1,688,412		2,405,627	2,765,678
General administrative expenses	387,897		378,905		732,251	743,567
Clinical development expenses	2,017,145		1,004,848		2,455,049	2,846,909
Other development expenses	1,082,111		1,487,988		4,449,344	4,118,356
Total operating expenses	7,623,351		8,684,304		16,729,109	18,781,931
Net loss	(9,434,208)		(8,327,897)		(17,923,175)	(18,931,374)
Reconciling Item [Member]
Segment Expenses [Abstract]
Interest income	333,624		675,209		711,473	1,344,104
Interest expense	(2,144,481)		(1,187,971)		(3,075,359)	(2,362,716)
Benefit from income taxes	$ 0		$ 869,169		$ 1,169,820	$ 869,169